This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan;178(1):32-33.

doi: 10.1111/bjd.15861.

Pigmentary evolution with pembrolizumab use

S J E Hwang^{1

2}, P Fernandez-Penas^{1

2}

Affiliations

Affiliations

¹ Sydney Medical School, The University of Sydney, Sydney, Australia.
² Department of Dermatology, Westmead Hospital, Hawkesbury Road, Westmead Sydney, New South Wales, 2145, Australia.

PMID: 29357597
DOI: 10.1111/bjd.15861

Comment

Pigmentary evolution with pembrolizumab use

S J E Hwang et al. Br J Dermatol. 2018 Jan.

. 2018 Jan;178(1):32-33.

doi: 10.1111/bjd.15861.

Authors

S J E Hwang^{1

2}, P Fernandez-Penas^{1

2}

Affiliations

¹ Sydney Medical School, The University of Sydney, Sydney, Australia.
² Department of Dermatology, Westmead Hospital, Hawkesbury Road, Westmead Sydney, New South Wales, 2145, Australia.

PMID: 29357597
DOI: 10.1111/bjd.15861

No abstract available

PubMed Disclaimer

Comment on

A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma.
Wolner ZJ, Marghoob AA, Pulitzer MP, Postow MA, Marchetti MA. Wolner ZJ, et al. Br J Dermatol. 2018 Jan;178(1):265-269. doi: 10.1111/bjd.15354. Epub 2017 Sep 21. Br J Dermatol. 2018. PMID: 28132411 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions